Allosteric Binding in Antibodies and Protein Antigens

抗体和蛋白质抗原的变构结合

基本信息

  • 批准号:
    8131731
  • 负责人:
  • 金额:
    $ 20.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-12 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The widespread exploitation of monoclonal antibodies for medical research activities, therapeutic treatments, and medical diagnostic immunoassays constitutes a multi-billion dollar health care industry. This project will investigate two types of novel synergistic binding reactions recently described for selected antibody- antigen pairs: those where the affinity of the antibody appeared to increase as the antigen concentration increased (positive cooperativity); and those where the affinity of an antibody directed toward one epitope on a protein antigen appeared to increase in the presence of a second antibody directed toward a different, separate epitope on the same protein antigen. Analytical experiments are proposed with the goal of understanding the molecular mechanisms of these novel synergistic binding reactions. Methods include, but are not limited to, analytical ultracentrifugation, asymmetric field flow fractionation, isothermal titration and differential scanning calorimetry, and circular dichroism and other spectroscopic measurements. Specific aims 1 and 3 are to conduct detailed structural and functional studies on monoclonal antibodies that exhibit synergistic binding behavior with their respective antigens. Practical goals include (i) the determination of antigen binding stoichiometries for antibodies that exhibit apparent Hill coefficients below and above 2.0 and (ii) the observation and correlation of antibody conformational changes to antigen binding. Specific aim 2 is to conduct functional and structural studies on protein antigens that bind monoclonal antibodies to separate epitopes in a synergistic manner. The principal goal of this aim is to quantify the relative contributions of both avidity effects and binding-dependent protein conformation changes to the apparent synergy of binding. In both aims, the unifying hypothesis is that the underlying molecular mechanisms are protein conformation changes that occur as a consequence of the antibody-antigen binding interaction. Any attempts to exploit antibodies that exhibit novel synergistic binding properties to enhance current clinical diagnostic or therapeutic applications must be dependent on existing knowledge concerning the molecular mechanisms whereby the novel binding is expressed. This project is expected to contribute fundamental knowledge toward manipulating these unexpected activities for diagnostic and therapeutic applications. It will also contribute to a basic understanding of a heretofore unrecognized aspect of antibody function.
描述(由申请人提供):单克隆抗体用于医学研究活动、治疗性治疗和医学诊断免疫测定的广泛开发构成了数十亿美元的医疗保健行业。本计画将研究两种最近被描述的针对特定抗体-抗原对的新型协同结合反应:抗体的亲和力随抗原浓度增加而增加的反应。(积极协同性);以及其中针对蛋白质抗原上的一个表位的抗体的亲和力在针对不同表位的第二抗体存在下似乎增加的那些,在相同的蛋白质抗原上有不同的表位。分析实验提出了理解这些新的协同结合反应的分子机制的目标。方法包括但不限于分析超离心、不对称场流分级、等温滴定和差示扫描量热法以及圆二色性和其它光谱测量。具体目标1和3是对表现出与其各自抗原的协同结合行为的单克隆抗体进行详细的结构和功能研究。实际目标包括(i)确定表现出低于和高于2.0的表观希尔系数的抗体的抗原结合化学计量,以及(ii)观察抗体构象变化与抗原结合的相关性。具体目标2是对以协同方式将单克隆抗体结合到单独表位的蛋白质抗原进行功能和结构研究。这个目标的主要目标是量化的相对贡献的亲合力效应和结合依赖性蛋白质的构象变化的结合的表观协同作用。在这两个目标中,统一的假设是,潜在的分子机制是由于抗体-抗原结合相互作用而发生的蛋白质构象变化。任何利用表现出新的协同结合特性的抗体来增强当前临床诊断或治疗应用的尝试必须依赖于关于表达新结合的分子机制的现有知识。该项目预计将有助于操纵这些意想不到的活动的诊断和治疗应用的基础知识。它也将有助于对抗体功能的一个迄今未被认识的方面的基本理解。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Electrospray ionization-ion mobility spectrometry identified monoclonal antibodies that bind exclusively to either the monomeric or a dimeric form of prostate specific antigen.
电喷雾电离离子迁移率识别单克隆抗体,这些抗体仅与前列腺特异性抗原的单体或二聚体形式结合。
  • DOI:
    10.1021/ac301527v
  • 发表时间:
    2012-08-07
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Blake, Robert C., II;Blake, Diane A.
  • 通讯作者:
    Blake, Diane A.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert C Blake其他文献

Expression and purification of the HTLV-1 transforming protein Tax
  • DOI:
    10.1186/1742-4690-8-s1-a145
  • 发表时间:
    2011-06-06
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Whitney Evans;Patrick Carriere;Morgan Weber;Lynez Preyan;Boguslawa Korona;Robert C Blake;Vicki Traina-Dorge;Maureen Shuh
  • 通讯作者:
    Maureen Shuh

Robert C Blake的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert C Blake', 18)}}的其他基金

Allosteric Binding in Antibodies and Protein Antigens
抗体和蛋白质抗原的变构结合
  • 批准号:
    7684654
  • 财政年份:
    2008
  • 资助金额:
    $ 20.53万
  • 项目类别:
Allosteric Binding in Antibodies and Protein Antigens
抗体和蛋白质抗原的变构结合
  • 批准号:
    7499132
  • 财政年份:
    2008
  • 资助金额:
    $ 20.53万
  • 项目类别:
Allosteric Binding in Antibodies and Protein Antigens
抗体和蛋白质抗原的变构结合
  • 批准号:
    7920187
  • 财政年份:
    2008
  • 资助金额:
    $ 20.53万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 20.53万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 20.53万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 20.53万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.53万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 20.53万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 20.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 20.53万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 20.53万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 20.53万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 20.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了